|Profile & Milestones|
Based in San Antonio, Texas, OncoVista was incorporated in 2004 and utilizes state-of-the-art drug discovery technologies, innovative clinical development and registration strategies as well as emerging technologies to bring to market new, safe and highly effective anti-cancer drugs.
Company founded based on two key platform technologies
Acquired majority share in AdnaGen AG
Merged with Aengus Pharmaceuticals
Initiated Phase I/II clinical trial for leukemia at two US sites
Entered into a Stock Purchase Agreement with a buyer whereby the Company sold all of its AdnaGen AG majority holding representing approximately 78% of the total issued and outstanding shares.